Document:

Exhibit
10.1

 

SEVERANCE AND CONSULTING SERVICES AGREEMENT

 

This SEVERANCE
AND CONSULTING SERVICES AGREEMENT (“Agreement”) is made as of this
12th day of September, 2008 (“Resignation Date”) by and between  Stanley N. Lapidus of Bedford, New Hampshire (“you” or the “Consultant”),
and Helicos BioSciences Corporation (the “Company”), which has its headquarters
at One Kendall Square, Building 700, Cambridge, Massachusetts, 02139. 

 

Therefore, in consideration
of the mutual covenants hereinafter recited, and additional consideration, the
sufficiency of which is hereby acknowledged, the parties agree as follows:

 

1.             Termination of
Employment: This confirms that you are hereby resigning from
employment with the Company effective as of the Resignation Date.  On or before the Company’s first payroll date
following the Resignation Date, the Company shall pay you all salary through
the Resignation Date plus all pay for all accrued but unused vacation.

 

2.             Severance Pay: The Company shall
pay you severance pay in the aggregate amount of $183,750 as follows:

 

(a)   regular payments made in equal
installments over the 18-month period beginning with the first payroll date in October 2008
(the “Severance Period”), at the gross monthly rate of $10,208.33.  Solely for purposes of Section 409A of
the Internal Revenue Code of 1986 (“Section 409A”), each installment
payment is considered a separate payment.

 

(b)   Notwithstanding the foregoing,
the amounts payable under Section 2(a) that are subject to Section 409A
(i.e., amounts payable after March 15, 2009) shall not commence until at
least six months and a day after the date of your “separation from service”
(within the meaning of Section 409A). 
We hereby agree that the Resignation Date is the date of your separation
from service.

 

3.             Benefits:  During
the Severance Period you shall be eligible to participate in the Company’s
group medical and dental plans at your current coverage levels, subject to
premium contributions by you to the same extent as premium contributions are
required for active employees with the same coverage levels. The date of the
expiration of the Severance Period shall be the date of the “qualifying event”
under the Company’s group medical and dental plans for the purpose of
continuation of coverage pursuant to the Consolidated Omnibus Budget
Reconciliation Act of 1985 (“COBRA”). 
The Company will present you with information on COBRA under separate
cover.  If you timely elect continuation
of coverage under COBRA, you shall be entitled to coverage under the Company’s
group medical and dental plans in which you are currently participating (“Group
Health Plans”) at the coverage levels that currently apply to you, subject to
payment solely by you of any premiums at the then current rate required for
active employees with the same coverage levels, effective until the COBRA
continuation period ends.

 

 

4.             Equity
Awards:  As of the
Resignation Date, the option granted to you (the “Option”) to purchase
355,555 shares of common stock of the Company pursuant to the Incentive Stock
Option Agreement dated March 28, 2006 (the “Option Agreement”) shall
vest in its entirety and become fully exercisable.  You agree that, except following a Change in
Control (as defined below), you will not exercise the Option with respect to
any shares which otherwise would have become exercisable after March 31,
2009.  In addition, the Option shall be
exercisable through the 90th day following the expiration of the Severance
Period.  In connection with the
modification of the Option, you acknowledge that the Option will no longer
qualify as an incentive stock option. 
Except as provided for herein, the Option Agreement shall continue in
full force and effect.

 

For the purposes of this Section 4, a “Change
in Control” shall be deemed to have occurred upon the occurrence of any one of
the following events:

 

(a)   any “Person,” as such term is
used in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934, as amended (the “Act”) (other than the Company, any of its subsidiaries,
or any trustee, fiduciary or other person or entity holding securities under
any employee benefit plan or trust of the Company or any of its subsidiaries),
together with all “affiliates” and “associates” (as such terms are defined in Rule 12b-2
under the Act) of such person, shall become the “beneficial owner” (as such
term is defined in Rule 13d-3 under the Act), directly or indirectly, of
securities of the Company representing 50 percent or more of the combined
voting power of the Company’s then outstanding securities having the right to
vote in an election of the Board (“Voting Securities”) (in such case other than
as a result of an acquisition of securities directly from the Company);

 

(b)   persons who, as of the date
hereof, constitute the Board (the “Incumbent Directors”) cease for any reason,
including, without limitation, as a result of a tender offer, proxy contest,
merger or similar transaction, to constitute at least a majority of the Board,
provided that any person becoming a director of the Company subsequent to the
date hereof shall be considered an Incumbent Director if such person’s election
was approved by or such person was nominated for election by either (i) a
vote of at least a majority of the Incumbent Directors or (ii) a vote of
at least a majority of the Incumbent Directors who are members of a nominating
committee comprised, in the majority, of Incumbent Directors; but provided
further, that any such person whose initial assumption of office is in
connection with an actual or threatened election contest relating to the
election of members of the Board of Directors or other actual or threatened
solicitation of proxies or consents by or on behalf of a Person other than the
Board, including by reason of agreement intended to avoid or settle any such
actual or threatened contest or solicitation, shall not be considered an
Incumbent Director;

 

(c)   the consummation of (i) any
consolidation or merger of the Company where the stockholders of the Company,
immediately prior to the consolidation or merger, would not, immediately after
the consolidation or merger, beneficially own (as such term is defined in Rule 13d-3
under the Act), directly or indirectly, shares representing in the aggregate
more than 50 percent of the 

 

2

 

voting shares of the Company
issuing cash or securities in the consolidation or merger (or of its ultimate
parent corporation, if any), or (ii) any sale, lease, exchange or other
transfer (in one transaction or a series of transactions contemplated or
arranged by any party as a single plan) of all or substantially all of the
assets of the Company; or

 

(d)   the approval by the Company’s
stockholders of any plan or proposal for the liquidation or dissolution of the
Company.

 

5.             Consulting Services:  As part
of the consideration for the payments and benefits following the Resignation
Date pursuant to Sections 2, 3 and 4, you will be available to
provide business advice upon the request of the Board or the Chief Executive
Officer and President of the Corporation (the “CEO”) and perform any
additional services agreed to in writing by the parties hereto (the “Services”).  You will not be expected to commit more than
20 hours per month in connection with the delivery of the Services.  Any work product, arising from the Services,
including work-in-process, will be referred to as the “Deliverables.”  The CEO will be the principal point of
contact.  In order to facilitate your
performance of the Services, the Company will provide you with the use of a
Company e-mail address for use solely in connection with the Services and
Deliverables (the “Email Address”) and laptop computer for the Severance
Term.  You acknowledge that you shall not
be provided with any secretarial or administrative support or a Blackberry or similar
device.

 

6.             Documents, Records,
etc.:  All documents, records, data,
apparatus, equipment and other physical property, whether or not pertaining to
information of a competitively sensitive or proprietary nature, which are
furnished to you by the Company or are produced by you in connection with any
services you perform under Section 5 hereof will be and remain the sole
property of the Company and are only to be used by you in connection with the
Services you are providing for the Company. 
You shall return to the Company all such materials and property as and
when requested by the Company.  In any
event, you will return all such materials and property immediately upon the
expiration of the Severance Period, including but in no way limited to such materials
that may be on your or another personal computer or device that is under your
control and is not otherwise related to the Company.  Upon expiration of the Severance Period, and
after you have provided to the Company copies of all of the Company’s documents
and property, including, without limitation, all Deliverables, you will
promptly delete duplicates of any of the Company’s materials and property from
any such computer or device to the extent that such materials or property
relate to such Services or the Deliverables. 
You will not, without the express written consent of the Company,
retain, remove or transmit (by electronic mail or otherwise) any such material
or property or any copies thereof after the completion of Services or has been
determined to take place.  You further
understand that the Company’s information systems, including electronic mail,
voicemail, and the Company’s computer systems, are the Company’s property.  You understand and acknowledge that the
Company may obtain access to all information maintained on the Company’s
property and that you have no personal privacy interest in any such
information.  The Company may waive all
or part of its rights arising from this Section 6 without affecting the
enforceability of the remainder of the provision or any other parts of the
Agreement.

 

7.             Director
Compensation: You hereby waive any
compensation under the Company’s Non-Employee Director Compensation Policy
which may be payable to you for 

 

3

 

services as a director of the Company and/or Chairman of
the Board during any time prior to the expiration of the Severance Period.

 

8.             Taxes:  The Company shall undertake to
make deductions, withholdings and tax reports with respect to payments and benefits
under this Agreement to the extent that it reasonably and in good faith
determines that it is required to make such deductions, withholdings and tax
reports.  Payments under this Agreement
shall be in amounts net of any such deductions or withholdings.  You acknowledge that neither the Company nor
its counsel has advised you about the taxability of any monies paid under this
Agreement, and that any tax advice you choose to seek concerning such monies
will be your responsibility, and obtained from a source independent of the
Company and at your own expense.

 

The parties intend that this letter will be administered in accordance
with Section 409A of the Code.  The
parties agree that this letter may be amended, as reasonably requested by
either party, and as may be necessary to fully comply with Section 409A of
the Code and all related rules and regulations in order to preserve the
payments and benefits provided hereunder without additional cost to either
party.

 

9.             Noncompetition, and Nondisclosure and Developments Agreement:  You agree that (a) the Non-Competition and Non-Solicitation Agreement between you and the
Company, dated October 21, 2003 (the “Non-Competition Agreement”) provides
restrictions so long as you have a Business Relationship (as defined therein),
which includes service as a director, and (b) the Employee Non-Disclosure and Developments Agreement between you and the
Company, dated October 28, 2003 (the “Non-Disclosure Agreement”) provides restrictions regarding your conduct
following the termination of your employment. 
You agree that the agreements referenced in the preceding sentence are
valid and enforceable, and that you shall comply in all respects with the terms
of such agreements.

 

10.           Public
Speaking:  You acknowledge that, without prior written
consent of the CEO, which consent may be withheld for any reason or no reason
at all, you will not (a) make any public communications, including, but
not limited to, interviews, speaking engagements or written statements, or
agree to make any such communication, under the title of Chairman of the
Company or under the Company’s name or (b) send any communications from
the Email Address which do not pertain to the Services or Deliverables.

 

11.           Release: In exchange for
the Company’s promises set forth herein, and other good and valuable
consideration, the sufficiency of which is hereby acknowledged, you and your
representatives, agents, estate, heirs, successors and assigns, absolutely and
unconditionally hereby release, remise, discharge, indemnify and hold harmless
the Company Releasees (defined to include the Company and/or any of its
parents, subsidiaries or affiliates, predecessors, successors or assigns, and
its and their respective current and/or former partners, directors,
shareholders/stockholders, officers, employees, attorneys and/or agents, all
both individually and in their official capacities), from any and all actions
or causes of action, suits, claims, complaints, contracts, liabilities,
agreements, promises, torts, debts, damages, controversies, judgments, rights
and demands, whether existing or contingent, known or unknown, suspected or
unsuspected, which arise out of your employment with, change in employment
status with, and/or separation of employment from, the Company.  This release is intended by you to be all
encompassing and to act as a full and total release of any claims, whether
specifically enumerated herein or not, that you may have or have had against
the Company Releasees arising 

 

4

 

from
conduct occurring up to and through the date of this Agreement, including, but
not limited to, any claims arising from any federal, state or local law,
regulation or constitution dealing with either employment, employment benefits
or employment discrimination such as those laws or regulations concerning
discrimination on the basis of race, color, creed, religion, age, sex, sex
harassment, sexual orientation, national origin, ancestry, genetic carrier
status, handicap or disability, veteran status, any military service or
application for military service, or any other category protected under federal
or state law; any contract, whether oral or written, express or implied,
including without limitation, any letter offering employment and any stock
option agreement(s); any tort; any claim for equity or other benefits; or any
other statutory and/or common law claim. You not only release and discharge the
Company Releasees from any and all claims as stated above that you could make
on your own behalf or on behalf of others, but also those claims that might be
made by any other person or organization on your behalf, and you specifically
waive any right to recover any damage awards as a member of any class in a case
in which any claim(s) against the Company Releasees are made involving any
matters.

 

Notwithstanding the foregoing, nothing herein shall be deemed to release
or waive any claims arising from this Agreement, under the Option Agreement or
the Company’s 401(k) plan or any claims or rights arising under any
directors’ and officers’ liability insurance coverage (the “D&O
Coverage”) maintained by the Company or the Indemnification Agreement
between you and the Company (the “Indemnification Agreement”).  For the avoidance of doubt, the Company acknowledges
and agrees that you are not releasing the Company Releasees from any claims
under the D&O Coverage or the Indemnification Agreement.

 

12.           Waiver of Rights and
Claims Under the Age Discrimination in Employment Act of 1967: Since you are 40
years of age or older, you are being informed that you have or may have
specific rights and/or claims under the Age Discrimination in Employment Act of
1967 (ADEA) and you agree that:

 

(a)   in consideration for the Company’s
promises set forth herein, you specifically and voluntarily waive such rights
and/or claims under the ADEA you might have against the Company Releasees to
the extent such rights and/or claims arose prior to the date this Agreement was
executed;

 

(b)   you understand that rights or
claims under the ADEA which may arise after the date this Agreement is executed
are not waived by you;

 

(c)   you are advised that you may take
at least 21 days within which to consider the terms of this Agreement, subject
to Section 13(a) below, and you are advised to consult with an
attorney of your choice prior to executing this Agreement, and you acknowledge
that you have not been subject to any undue or improper influence interfering
with the exercise of your free will in deciding whether to consult with
counsel;

 

(d)   you have carefully read and fully
understand all of the provisions of this Agreement, and you knowingly and
voluntarily agree to all of the terms set forth in this Agreement; and

 

(e)   in entering into this Agreement
you are not relying on any representation, promise or inducement made by the
Company or its attorneys with the exception of those promises described in this
document.

 

5

 

13.           Period for Review
and Consideration of Agreement:

 

(a)   You acknowledge that you were
informed and understood that you had 21 days from August 22, 2008 (i.e., to and including September 12, 2008) to review
and consider a preceding version of this Agreement before signing it.  You further acknowledge and agree that the
revisions to such preceding version that are reflected in this Agreement do not
extend that 21 day period.  If you sign
this Agreement before September 12, 2008, you acknowledge that such
decision was entirely voluntary. 

 

(b)   The 21-day review period will not
be affected or extended by any revisions, whether material or immaterial, that
might be made to this Agreement.

 

14.           Accord and
Satisfaction:  The payments set
forth herein shall be complete and unconditional payment, settlement, accord
and/or satisfaction with respect to all obligations and liabilities of the
Company Releasees to you, including, without limitation, all claims for back
wages, salary, vacation pay, draws, incentive pay, bonuses, stock and stock
options, commissions, severance pay, reimbursement of expenses, motor vehicle
expenses, moving expenses, any and all other forms of compensation or benefits,
attorney’s fees, or other costs or sums.

 

15.           No Liability or
Wrongdoing: 
Nothing in this Agreement, nor any of its terms and provisions, nor any
of the negotiations or proceedings connected with it, constitutes, will be
construed to constitute, will be offered in evidence as, received in evidence
as, and/or deemed to be evidence of, an admission of liability or wrongdoing by
any and/or all of the Company Releasees, and any such liability or wrongdoing
is hereby expressly denied by each of the Company Releasees.

 

16.           Assignment:  The rights and liabilities of the parties
hereto shall bind and inure to the benefit of their respective successors,
heirs, executors and administrators, as the case may be; provided that,
as the Company has specifically contracted for your services, you may not
assign or delegate your obligations under this Agreement either in whole or in
part without the Company’s prior written consent.

 

17.           Governing Law;
Severability:  This Agreement
shall be governed by and construed in accordance with the laws of the
Commonwealth of Massachusetts, excluding that body of law applicable to choice
of law.  If any provision of this
Agreement is for any reason found by a court of competent jurisdiction to be
unenforceable, the remainder of this Agreement shall continue in full force and
effect.

 

18.           Complete Understanding;
Modification:  You acknowledge
that, in connection with your resignation as Chief Executive Officer, the
Change of Control Agreement between you and the Company, dated May 7,
2007, terminated in accordance with Section 6 thereof.  You further acknowledge that, except with
respect to the Option Agreement, the Non-Competition
Agreement and the Non-Disclosure Agreement, this Agreement supersedes all
prior agreements and understandings between the parties with respect to its
subject matter and may not be changed unless mutually agreed upon in writing by
both parties.

 

19.           Notices:  Any notices required or permitted hereunder
shall be given to the appropriate party at the address specified below or at
such other address as the party shall specify 

 

6

 

in
writing.  Such notice shall be deemed
given upon personal delivery to the appropriate address or sent by certified or
registered mail, three days after the date of mailing provided that notice of
change of address shall be deemed effective only upon receipt.

 

20.           Effective Date:  After signing this letter, you may revoke
this Agreement for a period of seven days following said execution, by
providing written notification of such revocation to Robert F. Higgins, which
shall be received no later than seven days following said execution.  The Agreement shall not become effective or
enforceable and no payments will be made pursuant to this Agreement until this
revocation period has expired (“Effective Date”).

 

Remainder of Page Intentionally Left Blank

 

7

 

IN WITNESS WHEREOF, the parties hereto have signed this
Agreement as of the date first written above.

 

	
  Helicos
  BioSciences Corporation 

  	
   

  	
  Stanley
  N. Lapidus

  
	
   

  	
   

  	
   

  
	
  By:
  

  	
   

  	
   

  	
  By:

  	
   

  
	
  Title:

  	
   

  	
   

  	
   

  

 

8exhibit10_3.htm

    SHARE
PURCHASE AGREEMENT

    

    THIS SHARE PURCHASE AGREEMENT
dated as of the 11th day of
September, 2008,

    

    BETWEEN:

    

    Shaun P.
Davis, of 11730 - NE 107th Place,
Kirkland, Washington, 98033

    

    (the
“Purchaser”)

    

    
      	
              AND:

            

    

    

    Feliberto
Gurat, of 1403 - 1200 Alberni Street, Vancouver, British Columbia, V6E
1A6

    

    (“Gurat”)

    

    WHEREAS:

    

    
      	
              A.

            	
              Gurat
      is the registered and beneficial owner of 22,000,000 restricted common
      shares in the capital of Gurata Gold, Inc. (the “Shares”);

            

    

    

    
      	
              B.

            	
              Gurat
      wishes to sell and the Purchaser wishes to purchase the Shares pursuant to
      the terms and conditions of this
agreement;

            

    

    

    NOW THEREFORE THIS AGREEMENT
WITNESSES that for and in consideration of $1.00 and other good and
valuable consideration paid by each party to the other, the receipt and
sufficiency of which are acknowledged, the parties covenant and agree as
follows:

    

    
      	
              1.

            	
              Gurat
      agrees to sell and the Purchaser agrees to purchase the Shares for and at
      a price of US$22,000 (the “Purchase Price”) at the
      date of this agreement.

            

    

    

    
      	
              2.

            	
              The
      Purchaser will deliver to Gurat US$22,000 (the “Purchase Price”) as
      consideration for the transfer of the Shares to the Purchaser from
      Gurat.

            

    

    

    
      	
              3.

            	
              Gurat
      represents and warrants to the Purchaser
that:

            

    

    

    
      	
               
      

            	
              a.

            	
              Gurat
      owns the Shares as the legal and beneficial owner thereof, free of all
      liens, claims, charges and encumbrances of every nature and kind
      whatsoever.  The Shares are fully paid and non-assessable and
      Gurat has due and sufficient right and authority to enter into this
      agreement and to transfer the legal and beneficial title and ownership of
      the Shares to the Purchaser.

            

    

    

    
      	
               
      

            	
              b.

            	
              No
      person, firm or corporation has any agreement or option or a right capable
      of becoming an agreement for the purchase of the Shares, with the
      exception of this agreement.

            

    

    

    
      	
               
      

            	
              c.

            	
              Gurat
      is a resident of Canada within the meaning of Section 116 of the Income Tax Act (Canada).

            

    

    

    
      	
              4.

            	
              The
      effective date of sale and purchase of the Shares will be September 11,
      2008 (the “Closing
      Date”).

            

    

    

    
      	
              5.

            	
              On
      the Closing Date,

            

    

    

    
      	
              a.  

            	
              Gurat
      will deliver to the Purchaser the share certificates, duly endorsed for
      transfer, representing the Shares,
and

            

    

    

    
      	
              b.  

            	
              the
      Purchaser will deliver a certified cheque or solicitor’s trust cheque
      payable to “Feliberto Gurat” in the amount of US$22,000 as full payment of
      the Purchase Price.

            

    

    

    
      	
              6.

            	
              This
      agreement will enure to the benefit of and will be binding upon the
      parties and their respective successors and
  assigns.

            

    

    

    
      	
              7.

            	
              Time
      will be of the essence of this
agreement.

            

    

     

    
      	
              8.

            	
              The
      parties will sign such further assurances and other documents and
      instruments and do such further and other things as may be necessary to
      implement and carry out the intent of the
  agreement.

            

    

    

    

    IN WITNESS WHEREOF the parties
have signed this Share Purchase Agreement as of the day and year first above
written.

    

    

    

    

    

    

     /s/
Shaun P. Davis

    

      Shaun
P. Davis

    

    

    

    

    

    

     /s/
Feliberto Gurat

    

      Feliberto
Gurat

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00147-of-00352.parquet"}]]